Editas Medicine, Inc. (EDIT)
NASDAQ: EDIT · Real-Time Price · USD
2.820
+0.010 (0.36%)
At close: Aug 14, 2026, 4:00 PM EDT
2.840
+0.020 (0.71%)
After-hours: Aug 14, 2026, 7:34 PM EDT
Editas Medicine Market Cap
Editas Medicine has a market cap or net worth of $433.1 million as of August 14, 2026. Its market cap has increased by 56.38% in one year.
Market Cap
433.10M
Enterprise Value
236.96M
1-Year Change
56.38%
Ranking
Category
Stock Price
$2.82
ChartMarket Cap Chart
Since February 3, 2016, Editas Medicine's market cap has decreased from $620.67M to $433.10M, a decrease of -30.22%. That is a compound annual growth rate of -3.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 433.10M | 116.42% |
| Dec 31, 2025 | 200.12M | 90.89% |
| Dec 31, 2024 | 104.84M | -87.33% |
| Dec 29, 2023 | 827.35M | 38.68% |
| Dec 30, 2022 | 596.59M | -66.78% |
| Dec 31, 2021 | 1.80B | -58.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Puma Biotechnology | 455.81M |
| Larimar Therapeutics | 455.11M |
| Prothena Corporation | 454.85M |
| Q32 Bio | 451.01M |
| Inhibikase Therapeutics | 438.80M |
| Eupraxia Pharmaceuticals | 438.27M |
| Benitec Biopharma | 431.49M |
| SL Science Holding | 429.92M |